Verification of the folkloric and anecdotal antidiabetic effects of Hypoxis hemerocallidea (Fisch., C.A. Mey. & Avé-Lall) and isolated, β-sitosterol using early-stage type II spontaneous diabetic mutant BKS-Leprdb mice

Background Previous studies in our laboratory in ex vivo assays have demonstrated H. hemerocallidea extract as potential antidiabetic agent through increased insulin release from pancreatic beta cells. Thus, for this study the early stage type II spontaneous diabetic mutant mice model was used to ev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC complementary and alternative medicine 2022-06, Vol.22 (1), p.163-163, Article 163
Hauptverfasser: Mkolo, N. M., Olaokun, O. O., King, P. H., Janse van Rensburg, I., Eloff, J. N., Naidoo, V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 163
container_issue 1
container_start_page 163
container_title BMC complementary and alternative medicine
container_volume 22
creator Mkolo, N. M.
Olaokun, O. O.
King, P. H.
Janse van Rensburg, I.
Eloff, J. N.
Naidoo, V.
description Background Previous studies in our laboratory in ex vivo assays have demonstrated H. hemerocallidea extract as potential antidiabetic agent through increased insulin release from pancreatic beta cells. Thus, for this study the early stage type II spontaneous diabetic mutant mice model was used to evaluate and determine the degree of the antidiabetic efficacy of H. hemerocallidea. Methods Eight-weeks-old type II spontaneous pre-diabetic mutant BKS-Leprdb mice were fed with feed supplemented with either H. hemerocallidea extract, isolated compound (β-sitosterol) or chlorpropamide (positive control) for 4 weeks. The haematological parameters, clinical chemistry, glucose tolerance, feed intake, faecal output and body weights were measured. Results The blood glucose concentrations of all the animals treated with plant extract, β-sitosterol compound and non-treated pre-diabetic animals did not return to baseline levels. Only the β-sitosterol treatment and positive control groups resulted in a respective small decrease of 5.8 and 5.2% in the mouse weights over the study period, with no significant changes (p > 0.05) in food intake. However, there was a general trend for decrease in faecal output for all the groups. Albumin, triglycerides, and total cholesterol levels in β-sitosterol and chlorpropamide-treated animals were lower, relative to untreated-animals. Animals fed with plant extract showed large amounts of internal fat. There were no significant changes (p > 0.05) in total serum protein, globulin, alanine aminotransferase, alkaline phosphatase, urea nitrogen and creatinine attributed to administration of treatments. In all groups, some animals showed lesions associated with cardiac puncture. Few animals except animals treated with plant extract, showed presence of a left-ventricular hypertrophic cardiomyopathy. The liver and kidneys for all groups appeared macroscopically normal and the thymuses were small (±2 mg). There were pathological signs in some of the animals particularly in myocardial fibres, renal tubular, glomerular, hepatocyte granularity and pancreas islets. However, there was no significance trend between the groups. Conclusion Based on the results, none of the treatments could be considered highly effective for the management of type II pre-diabetes as sole therapeutic intervention.
doi_str_mv 10.1186/s12906-022-03640-y
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9208228</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2718261982</sourcerecordid><originalsourceid>FETCH-LOGICAL-c285y-67cb213a4c32c6bf2a812b8adf57411cc36ac87652ce42c5ade0eb7e3cf8bc663</originalsourceid><addsrcrecordid>eNqFks1u1DAUhSMEolXpC7CyhISK1Az29cTJbJCGEaUjBrHgZ2s5zs2MixMH26nII7HtK3TPE_AwuJ2qAjYsLF_5fj46vj5Z9pTRGWOVeBkYLKjIKUBOuZjTfHqQHYIQkJeiZA__qA-y4xAuKKXAGS958Tg74EUJRcHhMPv1Bb1pjVbRuJ64lsQdktbZr9Z5o4nqm7RQNy4qm6poGqNqjKmFbYs6hps759PgvptAdtihd1pZaxpU5OTMBL2bnZLVbDkj73GakedkeXn9I98k5MWtuAnOqojNKfl5lQcTXYhJwpIxmH5LUHk75SGqLZI4DUjWaxIG18fkyY2B3JvpxnQUyet3H_MNDr6pSWc0PsketcoGPL7bj7LPZ28-rc7zzYe369Vyk2uoiikXpa6BcTXXHLSoW1AVg7pSTVuUc8a05kLpqhQFaJyDLlSDFOsSuW6rWgvBj7JXe91hrDtsNPbRKysHbzrlJ-mUkX93erOTW3cpF0ArgCoJnNwJePdtxBBll0aH1u7fKaFkFQi2qOD_qCgXwNO3lwl99g964Ubfp0kkasG4EMWcJgr2lPYuBI_tvW9G5U3U5D5qMkVN3kZNTvw3vSHKVA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2691366540</pqid></control><display><type>article</type><title>Verification of the folkloric and anecdotal antidiabetic effects of Hypoxis hemerocallidea (Fisch., C.A. Mey. &amp; Avé-Lall) and isolated, β-sitosterol using early-stage type II spontaneous diabetic mutant BKS-Leprdb mice</title><source>DOAJ Directory of Open Access Journals</source><source>SpringerLink Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Mkolo, N. M. ; Olaokun, O. O. ; King, P. H. ; Janse van Rensburg, I. ; Eloff, J. N. ; Naidoo, V.</creator><creatorcontrib>Mkolo, N. M. ; Olaokun, O. O. ; King, P. H. ; Janse van Rensburg, I. ; Eloff, J. N. ; Naidoo, V.</creatorcontrib><description>Background Previous studies in our laboratory in ex vivo assays have demonstrated H. hemerocallidea extract as potential antidiabetic agent through increased insulin release from pancreatic beta cells. Thus, for this study the early stage type II spontaneous diabetic mutant mice model was used to evaluate and determine the degree of the antidiabetic efficacy of H. hemerocallidea. Methods Eight-weeks-old type II spontaneous pre-diabetic mutant BKS-Leprdb mice were fed with feed supplemented with either H. hemerocallidea extract, isolated compound (β-sitosterol) or chlorpropamide (positive control) for 4 weeks. The haematological parameters, clinical chemistry, glucose tolerance, feed intake, faecal output and body weights were measured. Results The blood glucose concentrations of all the animals treated with plant extract, β-sitosterol compound and non-treated pre-diabetic animals did not return to baseline levels. Only the β-sitosterol treatment and positive control groups resulted in a respective small decrease of 5.8 and 5.2% in the mouse weights over the study period, with no significant changes (p &gt; 0.05) in food intake. However, there was a general trend for decrease in faecal output for all the groups. Albumin, triglycerides, and total cholesterol levels in β-sitosterol and chlorpropamide-treated animals were lower, relative to untreated-animals. Animals fed with plant extract showed large amounts of internal fat. There were no significant changes (p &gt; 0.05) in total serum protein, globulin, alanine aminotransferase, alkaline phosphatase, urea nitrogen and creatinine attributed to administration of treatments. In all groups, some animals showed lesions associated with cardiac puncture. Few animals except animals treated with plant extract, showed presence of a left-ventricular hypertrophic cardiomyopathy. The liver and kidneys for all groups appeared macroscopically normal and the thymuses were small (±2 mg). There were pathological signs in some of the animals particularly in myocardial fibres, renal tubular, glomerular, hepatocyte granularity and pancreas islets. However, there was no significance trend between the groups. Conclusion Based on the results, none of the treatments could be considered highly effective for the management of type II pre-diabetes as sole therapeutic intervention.</description><identifier>ISSN: 2662-7671</identifier><identifier>EISSN: 2662-7671</identifier><identifier>EISSN: 1472-6882</identifier><identifier>DOI: 10.1186/s12906-022-03640-y</identifier><identifier>PMID: 35725532</identifier><language>eng</language><publisher>London: BioMed Central</publisher><subject>Alanine ; Alanine transaminase ; Albumins ; Alkaline phosphatase ; Animals ; Antidiabetics ; Automation ; Beta cells ; blood glucose ; blood proteins ; Cardiomyopathy ; Cholesterol ; complement ; Creatinine ; Diabetes ; Diabetes mellitus ; Experiments ; feed intake ; Feeds ; Fibers ; Food intake ; Globulins ; Glucose ; Glucose tolerance ; Heart ; hypoglycemic agents ; Hypoxis hemerocallidea ; Insulin ; Kidneys ; liver ; mice ; Mutants ; NMR ; Nuclear magnetic resonance ; pancreas ; Plant extracts ; Plasma ; Serum proteins ; Solvents ; Sulfur ; therapeutics ; Triglycerides ; Urea ; urea nitrogen ; Ventricle</subject><ispartof>BMC complementary and alternative medicine, 2022-06, Vol.22 (1), p.163-163, Article 163</ispartof><rights>2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c285y-67cb213a4c32c6bf2a812b8adf57411cc36ac87652ce42c5ade0eb7e3cf8bc663</citedby><cites>FETCH-LOGICAL-c285y-67cb213a4c32c6bf2a812b8adf57411cc36ac87652ce42c5ade0eb7e3cf8bc663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208228/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208228/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Mkolo, N. M.</creatorcontrib><creatorcontrib>Olaokun, O. O.</creatorcontrib><creatorcontrib>King, P. H.</creatorcontrib><creatorcontrib>Janse van Rensburg, I.</creatorcontrib><creatorcontrib>Eloff, J. N.</creatorcontrib><creatorcontrib>Naidoo, V.</creatorcontrib><title>Verification of the folkloric and anecdotal antidiabetic effects of Hypoxis hemerocallidea (Fisch., C.A. Mey. &amp; Avé-Lall) and isolated, β-sitosterol using early-stage type II spontaneous diabetic mutant BKS-Leprdb mice</title><title>BMC complementary and alternative medicine</title><description>Background Previous studies in our laboratory in ex vivo assays have demonstrated H. hemerocallidea extract as potential antidiabetic agent through increased insulin release from pancreatic beta cells. Thus, for this study the early stage type II spontaneous diabetic mutant mice model was used to evaluate and determine the degree of the antidiabetic efficacy of H. hemerocallidea. Methods Eight-weeks-old type II spontaneous pre-diabetic mutant BKS-Leprdb mice were fed with feed supplemented with either H. hemerocallidea extract, isolated compound (β-sitosterol) or chlorpropamide (positive control) for 4 weeks. The haematological parameters, clinical chemistry, glucose tolerance, feed intake, faecal output and body weights were measured. Results The blood glucose concentrations of all the animals treated with plant extract, β-sitosterol compound and non-treated pre-diabetic animals did not return to baseline levels. Only the β-sitosterol treatment and positive control groups resulted in a respective small decrease of 5.8 and 5.2% in the mouse weights over the study period, with no significant changes (p &gt; 0.05) in food intake. However, there was a general trend for decrease in faecal output for all the groups. Albumin, triglycerides, and total cholesterol levels in β-sitosterol and chlorpropamide-treated animals were lower, relative to untreated-animals. Animals fed with plant extract showed large amounts of internal fat. There were no significant changes (p &gt; 0.05) in total serum protein, globulin, alanine aminotransferase, alkaline phosphatase, urea nitrogen and creatinine attributed to administration of treatments. In all groups, some animals showed lesions associated with cardiac puncture. Few animals except animals treated with plant extract, showed presence of a left-ventricular hypertrophic cardiomyopathy. The liver and kidneys for all groups appeared macroscopically normal and the thymuses were small (±2 mg). There were pathological signs in some of the animals particularly in myocardial fibres, renal tubular, glomerular, hepatocyte granularity and pancreas islets. However, there was no significance trend between the groups. Conclusion Based on the results, none of the treatments could be considered highly effective for the management of type II pre-diabetes as sole therapeutic intervention.</description><subject>Alanine</subject><subject>Alanine transaminase</subject><subject>Albumins</subject><subject>Alkaline phosphatase</subject><subject>Animals</subject><subject>Antidiabetics</subject><subject>Automation</subject><subject>Beta cells</subject><subject>blood glucose</subject><subject>blood proteins</subject><subject>Cardiomyopathy</subject><subject>Cholesterol</subject><subject>complement</subject><subject>Creatinine</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Experiments</subject><subject>feed intake</subject><subject>Feeds</subject><subject>Fibers</subject><subject>Food intake</subject><subject>Globulins</subject><subject>Glucose</subject><subject>Glucose tolerance</subject><subject>Heart</subject><subject>hypoglycemic agents</subject><subject>Hypoxis hemerocallidea</subject><subject>Insulin</subject><subject>Kidneys</subject><subject>liver</subject><subject>mice</subject><subject>Mutants</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>pancreas</subject><subject>Plant extracts</subject><subject>Plasma</subject><subject>Serum proteins</subject><subject>Solvents</subject><subject>Sulfur</subject><subject>therapeutics</subject><subject>Triglycerides</subject><subject>Urea</subject><subject>urea nitrogen</subject><subject>Ventricle</subject><issn>2662-7671</issn><issn>2662-7671</issn><issn>1472-6882</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNqFks1u1DAUhSMEolXpC7CyhISK1Az29cTJbJCGEaUjBrHgZ2s5zs2MixMH26nII7HtK3TPE_AwuJ2qAjYsLF_5fj46vj5Z9pTRGWOVeBkYLKjIKUBOuZjTfHqQHYIQkJeiZA__qA-y4xAuKKXAGS958Tg74EUJRcHhMPv1Bb1pjVbRuJ64lsQdktbZr9Z5o4nqm7RQNy4qm6poGqNqjKmFbYs6hps759PgvptAdtihd1pZaxpU5OTMBL2bnZLVbDkj73GakedkeXn9I98k5MWtuAnOqojNKfl5lQcTXYhJwpIxmH5LUHk75SGqLZI4DUjWaxIG18fkyY2B3JvpxnQUyet3H_MNDr6pSWc0PsketcoGPL7bj7LPZ28-rc7zzYe369Vyk2uoiikXpa6BcTXXHLSoW1AVg7pSTVuUc8a05kLpqhQFaJyDLlSDFOsSuW6rWgvBj7JXe91hrDtsNPbRKysHbzrlJ-mUkX93erOTW3cpF0ArgCoJnNwJePdtxBBll0aH1u7fKaFkFQi2qOD_qCgXwNO3lwl99g964Ubfp0kkasG4EMWcJgr2lPYuBI_tvW9G5U3U5D5qMkVN3kZNTvw3vSHKVA</recordid><startdate>20220620</startdate><enddate>20220620</enddate><creator>Mkolo, N. M.</creator><creator>Olaokun, O. O.</creator><creator>King, P. H.</creator><creator>Janse van Rensburg, I.</creator><creator>Eloff, J. N.</creator><creator>Naidoo, V.</creator><general>BioMed Central</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><scope>5PM</scope></search><sort><creationdate>20220620</creationdate><title>Verification of the folkloric and anecdotal antidiabetic effects of Hypoxis hemerocallidea (Fisch., C.A. Mey. &amp; Avé-Lall) and isolated, β-sitosterol using early-stage type II spontaneous diabetic mutant BKS-Leprdb mice</title><author>Mkolo, N. M. ; Olaokun, O. O. ; King, P. H. ; Janse van Rensburg, I. ; Eloff, J. N. ; Naidoo, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c285y-67cb213a4c32c6bf2a812b8adf57411cc36ac87652ce42c5ade0eb7e3cf8bc663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alanine</topic><topic>Alanine transaminase</topic><topic>Albumins</topic><topic>Alkaline phosphatase</topic><topic>Animals</topic><topic>Antidiabetics</topic><topic>Automation</topic><topic>Beta cells</topic><topic>blood glucose</topic><topic>blood proteins</topic><topic>Cardiomyopathy</topic><topic>Cholesterol</topic><topic>complement</topic><topic>Creatinine</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Experiments</topic><topic>feed intake</topic><topic>Feeds</topic><topic>Fibers</topic><topic>Food intake</topic><topic>Globulins</topic><topic>Glucose</topic><topic>Glucose tolerance</topic><topic>Heart</topic><topic>hypoglycemic agents</topic><topic>Hypoxis hemerocallidea</topic><topic>Insulin</topic><topic>Kidneys</topic><topic>liver</topic><topic>mice</topic><topic>Mutants</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>pancreas</topic><topic>Plant extracts</topic><topic>Plasma</topic><topic>Serum proteins</topic><topic>Solvents</topic><topic>Sulfur</topic><topic>therapeutics</topic><topic>Triglycerides</topic><topic>Urea</topic><topic>urea nitrogen</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mkolo, N. M.</creatorcontrib><creatorcontrib>Olaokun, O. O.</creatorcontrib><creatorcontrib>King, P. H.</creatorcontrib><creatorcontrib>Janse van Rensburg, I.</creatorcontrib><creatorcontrib>Eloff, J. N.</creatorcontrib><creatorcontrib>Naidoo, V.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC complementary and alternative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mkolo, N. M.</au><au>Olaokun, O. O.</au><au>King, P. H.</au><au>Janse van Rensburg, I.</au><au>Eloff, J. N.</au><au>Naidoo, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Verification of the folkloric and anecdotal antidiabetic effects of Hypoxis hemerocallidea (Fisch., C.A. Mey. &amp; Avé-Lall) and isolated, β-sitosterol using early-stage type II spontaneous diabetic mutant BKS-Leprdb mice</atitle><jtitle>BMC complementary and alternative medicine</jtitle><date>2022-06-20</date><risdate>2022</risdate><volume>22</volume><issue>1</issue><spage>163</spage><epage>163</epage><pages>163-163</pages><artnum>163</artnum><issn>2662-7671</issn><eissn>2662-7671</eissn><eissn>1472-6882</eissn><abstract>Background Previous studies in our laboratory in ex vivo assays have demonstrated H. hemerocallidea extract as potential antidiabetic agent through increased insulin release from pancreatic beta cells. Thus, for this study the early stage type II spontaneous diabetic mutant mice model was used to evaluate and determine the degree of the antidiabetic efficacy of H. hemerocallidea. Methods Eight-weeks-old type II spontaneous pre-diabetic mutant BKS-Leprdb mice were fed with feed supplemented with either H. hemerocallidea extract, isolated compound (β-sitosterol) or chlorpropamide (positive control) for 4 weeks. The haematological parameters, clinical chemistry, glucose tolerance, feed intake, faecal output and body weights were measured. Results The blood glucose concentrations of all the animals treated with plant extract, β-sitosterol compound and non-treated pre-diabetic animals did not return to baseline levels. Only the β-sitosterol treatment and positive control groups resulted in a respective small decrease of 5.8 and 5.2% in the mouse weights over the study period, with no significant changes (p &gt; 0.05) in food intake. However, there was a general trend for decrease in faecal output for all the groups. Albumin, triglycerides, and total cholesterol levels in β-sitosterol and chlorpropamide-treated animals were lower, relative to untreated-animals. Animals fed with plant extract showed large amounts of internal fat. There were no significant changes (p &gt; 0.05) in total serum protein, globulin, alanine aminotransferase, alkaline phosphatase, urea nitrogen and creatinine attributed to administration of treatments. In all groups, some animals showed lesions associated with cardiac puncture. Few animals except animals treated with plant extract, showed presence of a left-ventricular hypertrophic cardiomyopathy. The liver and kidneys for all groups appeared macroscopically normal and the thymuses were small (±2 mg). There were pathological signs in some of the animals particularly in myocardial fibres, renal tubular, glomerular, hepatocyte granularity and pancreas islets. However, there was no significance trend between the groups. Conclusion Based on the results, none of the treatments could be considered highly effective for the management of type II pre-diabetes as sole therapeutic intervention.</abstract><cop>London</cop><pub>BioMed Central</pub><pmid>35725532</pmid><doi>10.1186/s12906-022-03640-y</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2662-7671
ispartof BMC complementary and alternative medicine, 2022-06, Vol.22 (1), p.163-163, Article 163
issn 2662-7671
2662-7671
1472-6882
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9208228
source DOAJ Directory of Open Access Journals; SpringerLink Journals; PubMed Central; PubMed Central Open Access; Springer Nature OA Free Journals
subjects Alanine
Alanine transaminase
Albumins
Alkaline phosphatase
Animals
Antidiabetics
Automation
Beta cells
blood glucose
blood proteins
Cardiomyopathy
Cholesterol
complement
Creatinine
Diabetes
Diabetes mellitus
Experiments
feed intake
Feeds
Fibers
Food intake
Globulins
Glucose
Glucose tolerance
Heart
hypoglycemic agents
Hypoxis hemerocallidea
Insulin
Kidneys
liver
mice
Mutants
NMR
Nuclear magnetic resonance
pancreas
Plant extracts
Plasma
Serum proteins
Solvents
Sulfur
therapeutics
Triglycerides
Urea
urea nitrogen
Ventricle
title Verification of the folkloric and anecdotal antidiabetic effects of Hypoxis hemerocallidea (Fisch., C.A. Mey. & Avé-Lall) and isolated, β-sitosterol using early-stage type II spontaneous diabetic mutant BKS-Leprdb mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T15%3A47%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Verification%20of%20the%20folkloric%20and%20anecdotal%20antidiabetic%20effects%20of%20Hypoxis%20hemerocallidea%20(Fisch.,%20C.A.%20Mey.%20&%20Av%C3%A9-Lall)%20and%20isolated,%20%CE%B2-sitosterol%20using%20early-stage%20type%20II%20spontaneous%20diabetic%20mutant%20BKS-Leprdb%20mice&rft.jtitle=BMC%20complementary%20and%20alternative%20medicine&rft.au=Mkolo,%20N.%20M.&rft.date=2022-06-20&rft.volume=22&rft.issue=1&rft.spage=163&rft.epage=163&rft.pages=163-163&rft.artnum=163&rft.issn=2662-7671&rft.eissn=2662-7671&rft_id=info:doi/10.1186/s12906-022-03640-y&rft_dat=%3Cproquest_pubme%3E2718261982%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2691366540&rft_id=info:pmid/35725532&rfr_iscdi=true